Emergências e Terapia Intensiva

Comentários de estudo | Ventilação não invasiva para pacientes com COVID-19. Estudo Recovery RS.

23 Ago, 2021 | 13:18h

Comentário 1: JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial – St Emlyn’s

Comentário 2: An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19 – The Bottom Line

Estudo original: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP reduced the composite outcome of intubation or death within 30 days; high-flow nasal oxygenation was not associated with better outcomes.

---

Pesquisa | Maus-tratos no ambiente de trabalho são frequentemente reportados por residentes de medicina de emergência.

23 Ago, 2021 | 12:53h

Workplace Mistreatment Reported Frequently by Emergency Medicine Residents – HealthDay

Estudo original: Prevalence of Discrimination, Abuse, and Harassment in Emergency Medicine Residency Training in the US – JAMA Network Open

 

Comentário no Twitter

In this study, 45.1% of emergency medicine residents reported exposure to workplace mistreatment. Interventions should be developed to ensure resident wellness and career satisfaction. @ABEMCert @EmoryMedicine @NUFeinbergMed @Rutgers_NJMS @UWMedicine https://t.co/dTrUH14NxB

— JAMA Network Open (@JAMANetworkOpen) August 20, 2021

 

---

M-A de estudos randomizados | O efeito de maior ou menor aporte proteico em pacientes criticamente doentes – “Nesses pacientes, um alto aporte diário de proteína não esteve associado com qualquer melhora nos desfechos clínicos ou centrados no paciente.”

20 Ago, 2021 | 12:16h

The effect of higher versus lower protein delivery in critically ill patients: a systematic review and meta-analysis of randomized controlled trials – Critical Care

---

Variações de práticas de fim de vida em unidades de terapia intensiva pelo mundo: um estudo observacional prospectivo.

20 Ago, 2021 | 12:10h

Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study – The Lancet Respiratory Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

Limitation of life-sustaining therapies is common worldwide with regional variability. Withholding treatment is more common than withdrawing treatment. Variations in type, frequency, and timing of end-of-life decisions were observed. https://t.co/skfjazyt7x @LancetRespirMed

— Martijn A. Spruit (@pulmonary_rehab) August 9, 2021

 

---

Revisão | Patógenos respiratórios virais e lesão pulmonar.

20 Ago, 2021 | 12:05h

Viral Respiratory Pathogens and Lung Injury – Clinical Microbiology Reviews

---

Betalactamases de espectro estendido: uma atualização nas características, na epidemiologia e na detecção.

20 Ago, 2021 | 12:04h

Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection – JAC-Antimicrobial Resistance

---

Estudo do NIH mostra que não há nenhum benefício significativo do plasma convalescente para pacientes ambulatoriais de COVID-19 com sintomas iniciais.

19 Ago, 2021 | 12:29h

NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms – NIH News Releases

Estudo original: Early Convalescent Plasma for High-Risk Outpatients with Covid-19 – New England Journal of Medicine

 

Comentário no Twitter

Convalescent plasma did not prevent disease progression in patients seen in EDs within 7 days after the onset #COVID19 symptoms. https://t.co/9gmIK3ntKH #IDTwitter pic.twitter.com/sirzn1uGL0

— NEJM (@NEJM) August 18, 2021

 

---

Ponto de vista | Combatendo a variante Delta do SARS-CoV-2.

19 Ago, 2021 | 12:25h

Confronting the Delta Variant of SARS-CoV-2, Summer 2021 – JAMA

---

Linfo-histiocitose hemofagocítica secundária à COVID-19: uma série de casos.

19 Ago, 2021 | 12:19h

Haemophagocytic lymphohistiocytosis secondary to COVID-19: a case series – The Lancet Rheumatology

---

Delirium na doença crítica: manifestações clínicas, desfechos e tratamento.

18 Ago, 2021 | 12:46h

Delirium in critical illness: clinical manifestations, outcomes, and management – Intensive Care Medicine (se este link não funcionar, tente este)

Conteúdos relacionados:

M-A: Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients.

ICU Survivorship—The relationship of delirium, sedation, dementia, and acquired weakness.

Systematic review: In hospitalized non‐ICU patients, multicomponent non-pharmacological interventions are estimated to reduce the incidence of delirium by 43% compared to usual care.

 

Comentário no Twitter

Delirium in ICU
➡️definition/prevalence
➡️detection
➡️outcomes
➡️pharmacologic & non prevention/treatment
➡️future
Common, often misdiagnosed (under/overdiagnosed & trivialized): screen for with validated tool + approach with bundle of safety steps #FOAMcc https://t.co/2Aejq9uCm6 pic.twitter.com/MbxtyXZbaD

— Intens Care Med (@yourICM) August 17, 2021

 

---